Communiqués Edwards Lifesciences Corporation Börse Stuttgart

Actions

EWL

US28176E1082

Temps réel estimé Tradegate Autres places de cotation 13:06:29 26/06/2024			Varia. 5j.	Varia. 1 janv.
85,14 ^EUR	+1,75%		+3,65%	+20,77%

20/06	Un initié d'Edwards Lifesciences a vendu des actions d'une valeur de 492 258 $, selon un récent dépôt auprès de la SEC	MT
17/06	Edwards Lifesciences Corporation annonce des changements au sein de sa direction	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	05/06	BU
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	03/06	PR
Edwards Lifesciences to Sell Critical Care to BD	03/06	BU
Edwards Lifesciences : Charter of the Audit Committee	28/05	PU
Edwards Lifesciences : First Quarter 2024 Fact Sheet	15/05	PU
Edwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilité	09/05	BU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	09/05	BU
Edwards Lifesciences: Q1 Earnings Snapshot	25/04	AQ
Edwards Lifesciences Reports First Quarter Results	25/04	BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024	18/04	BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It	08/04	AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It	07/04	BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)	03/04	AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	11/03	BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE	26/02	AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference	23/02	BU
Edwards Lifesciences: Q4 Earnings Snapshot	06/02	AQ
Edwards Lifesciences Reports Fourth Quarter Results	06/02	BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve	02/02	BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024	30/01	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Edwards Lifesciences Corporation : L’histoire se poursuit

Le 23 avril 2024 à 10:36